# Cullinan Therapeutics, Inc.: filings

CGEM · Nasdaq · CIK 1789972 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cgem.md) · [Financials](/companies/cgem/financials.md) · [Filings](/companies/cgem/filings.md) · [Insiders](/companies/cgem/insiders.md)

## Reports and events: 101 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 220, 8-K 66, 3 27, 144 20, 10-Q 17, SC 13G/A 16, CORRESP 9, SC 13G 9, SCHEDULE 13G/A 9, S-8 7, 10-K 6, DEF 14A 6, DEFA14A 6, SCHEDULE 13G 5, UPLOAD 5, 4/A 3, ARS 3, EFFECT 3, S-1/A 3, S-3 2, SEC STAFF LETTER 2, 3/A 1, 424B3 1, 424B4 1, 5 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-1MEF 1, S-3/A 1, S-3ASR 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-02 | 23:35 ET | [8-K](/filings/0001193125-26-411011.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-411011 |
| 2026-09-24 | 11:15 ET | [8-K](/filings/0001193125-26-400144.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-400144 |
| 2026-09-14 | 11:29 ET | [8-K](/filings/0001193125-26-389844.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389844 |
| 2026-08-13 | 23:35 ET | [8-K](/filings/0001193125-26-347400.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-347400 |
| 2026-08-06 | 11:10 ET | [10-Q](/filings/0001193125-26-336717.md) | Quarterly report, period 2026-06-30 | 0001193125-26-336717 |
| 2026-08-06 | 11:06 ET | [8-K](/filings/0001193125-26-336700.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336700 |
| 2026-06-16 | 21:18 ET | [8-K](/filings/0001193125-26-272890.md) | 5.07 Shareholder vote results | 0001193125-26-272890 |
| 2026-06-10 | 11:32 ET | [8-K](/filings/0001193125-26-264916.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-264916 |
| 2026-06-08 | 10:32 ET | [8-K](/filings/0001193125-26-260640.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-260640 |
| 2026-05-18 | 21:30 ET | [8-K](/filings/0001193125-26-229173.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-229173 |
| 2026-05-07 | 11:08 ET | [10-Q](/filings/0001193125-26-210304.md) | Quarterly report, period 2026-03-31 | 0001193125-26-210304 |
| 2026-05-07 | 11:03 ET | [8-K](/filings/0001193125-26-210290.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210290 |
| 2026-04-28 | 10:50 ET | [DEF 14A](/filings/0001193125-26-183465.md) | Proxy statement, period 2026-04-27 | 0001193125-26-183465 |
| 2026-03-10 | 11:26 ET | [10-K](/filings/0001193125-26-099362.md) | Annual report, period 2025-12-31 | 0001193125-26-099362 |
| 2026-03-10 | 11:23 ET | [8-K](/filings/0001193125-26-099355.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-099355 |
| 2026-01-08 | 12:15 ET | [8-K](/filings/0001193125-26-006998.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-006998 |
| 2025-12-08 | 15:34 ET | [8-K](/filings/0001193125-25-310764.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310764 |
| 2025-11-21 | 21:30 ET | [8-K](/filings/0001193125-25-291448.md) | 1.02 Termination of a material agreement | 0001193125-25-291448 |
| 2025-11-06 | 12:13 ET | [10-Q](/filings/0001193125-25-268066.md) | Quarterly report, period 2025-09-30 | 0001193125-25-268066 |
| 2025-11-06 | 12:03 ET | [8-K](/filings/0001193125-25-268041.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-268041 |
| 2025-11-03 | 14:14 ET | [8-K](/filings/0001193125-25-261799.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-261799 |
| 2025-09-04 | 10:01 ET | [8-K](/filings/0000950170-25-112949.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-112949 |
| 2025-08-07 | 11:07 ET | [10-Q](/filings/0000950170-25-104551.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104551 |
| 2025-08-07 | 11:04 ET | [8-K](/filings/0000950170-25-104547.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-104547 |
| 2025-06-12 | 20:23 ET | [8-K](/filings/0000950170-25-085425.md) | 5.07 Shareholder vote results | 0000950170-25-085425 |
| 2025-06-04 | 20:04 ET | [8-K](/filings/0000950170-25-081601.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-081601 |
| 2025-05-08 | 11:24 ET | [10-Q](/filings/0000950170-25-066384.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066384 |
| 2025-05-08 | 11:21 ET | [8-K](/filings/0000950170-25-066382.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066382 |
| 2025-04-25 | 10:56 ET | [DEF 14A](/filings/0000950170-25-058316.md) | Proxy statement, period 2025-04-24 | 0000950170-25-058316 |
| 2025-02-27 | 12:07 ET | [10-K](/filings/0000950170-25-028346.md) | Annual report, period 2024-12-31 | 0000950170-25-028346 |
| 2025-02-27 | 12:03 ET | [8-K](/filings/0000950170-25-028343.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-028343 |
| 2025-01-29 | 12:00 ET | [8-K](/filings/0000950170-25-010199.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-010199 |
| 2024-11-07 | 12:18 ET | [10-Q](/filings/0000950170-24-122795.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122795 |
| 2024-11-07 | 12:06 ET | [8-K](/filings/0000950170-24-122778.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122778 |
| 2024-10-16 | 11:17 ET | [8-K](/filings/0000950170-24-114841.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-114841 |
| 2024-09-17 | 11:13 ET | [8-K](/filings/0000950170-24-107011.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-107011 |
| 2024-08-08 | 11:20 ET | [10-Q](/filings/0000950170-24-093320.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093320 |
| 2024-08-08 | 11:15 ET | [8-K](/filings/0000950170-24-093314.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093314 |
| 2024-06-27 | 21:00 ET | [8-K](/filings/0000950170-24-078554.md) | 5.07 Shareholder vote results | 0000950170-24-078554 |
| 2024-06-03 | 12:12 ET | [8-K](/filings/0000950170-24-067662.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-067662 |
| 2024-05-23 | 21:07 ET | [8-K](/filings/0000950170-24-064025.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-064025 |
| 2024-05-16 | 10:40 ET | [DEF 14A](/filings/0001193125-24-139976.md) | Proxy statement, period 2024-06-26 | 0001193125-24-139976 |
| 2024-05-15 | 20:31 ET | [10-Q](/filings/0000950170-24-060535.md) | Quarterly report, period 2024-03-31 | 0000950170-24-060535 |
| 2024-05-15 | 20:15 ET | [8-K](/filings/0000950170-24-060481.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-060481 |
| 2024-04-29 | 11:05 ET | [8-K](/filings/0000950170-24-049436.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-049436 |
| 2024-04-16 | 11:14 ET | [8-K](/filings/0000950170-24-044593.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-044593 |
| 2024-03-14 | 11:22 ET | [10-K](/filings/0000950170-24-031143.md) | Annual report, period 2023-12-31 | 0000950170-24-031143 |
| 2024-03-14 | 11:14 ET | [8-K](/filings/0000950170-24-031140.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-031140 |
| 2024-01-08 | 21:15 ET | [8-K/A](/filings/0000950170-24-002936.md) | 2.02 Results of operations | 0000950170-24-002936 |
| 2024-01-08 | 14:12 ET | [8-K](/filings/0000950170-24-002745.md) | 2.01 Completion of an acquisition or disposition | 0000950170-24-002745 |

Page 1 of 3. [Older](/companies/cgem/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.